DEC 25, 2020 7:38 PM PST

Class of Antibiotics May Target Resistant Bacteria

WRITTEN BY: Nouran Amin

Researchers found a new class of antibiotics for combatting antimicrobial resistance (AMR).

Learn more about antibiotic resistance:

"We took a creative, double-pronged strategy to develop new molecules that can kill difficult-to-treat infections while enhancing the natural host immune response," said Farokh Dotiwala, M.B.B.S., Ph.D., assistant professor in the Vaccine & Immunotherapy Center and lead author of the effort to identify a new generation of antimicrobials named dual-acting immuno-antibiotics (DAIAs).

Findings were published in Nature.

"We reasoned that harnessing the immune system to simultaneously attack bacteria on two different fronts makes it hard for them to develop resistance," said Dotiwala.

"Immune activation represents the second line of attack of the DAIA strategy," said Kumar Singh, Ph.D., Dotiwala lab postdoctoral fellow and first author of the study.

"We believe this innovative DAIA strategy may represent a potential landmark in the world's fight against AMR, creating a synergy between the direct killing ability of antibiotics and the natural power of the immune system," echoed Dotiwala.

Source: Science Daily

About the Author
Master's (MA/MS/Other)
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
DEC 02, 2022
Genetics & Genomics
Tips on Establishing a Reliable Cell Free DNA Workflow
Tips on Establishing a Reliable Cell Free DNA Workflow
Ever since its first discovery in 1948, circulating cell-free DNA (cfDNA) has captured the attention and imagination of ...
DEC 09, 2022
Cannabis Sciences
What are fast acting edibles, and how do they work?
What are fast acting edibles, and how do they work?
Fast acting edibles are one of the newest and most popular products on the market. Here's what's behind the fast acting ...
DEC 18, 2022
Health & Medicine
A Stem Cell Patch Could Be Used to Treat the Tissue Damage That Occurs After a Heart Attack
A Stem Cell Patch Could Be Used to Treat the Tissue Damage That Occurs After a Heart Attack
A myocardial infarction, also known as a heart attack, is a serious medical condition that occurs when the blood flow to ...
DEC 23, 2022
Drug Discovery & Development
Onchilles Pharma's Newest Drug
Onchilles Pharma's Newest Drug
Onchilles Pharma is a small pharmaceutical company based in San Diego, USA. They work in oncology pharmacy, specifically ...
FEB 03, 2023
Drug Discovery & Development
Tzield: Newest Type 1 Diabetes Drug
Tzield: Newest Type 1 Diabetes Drug
Type 1 Diabetes (T1D) is a autoimmune genetic disease that results in a person’s pancreas not making enough insuli ...
JAN 10, 2023
Health & Medicine
Liver Let Die: Dying Liver Cells Disclose Cancer Diagnosis
Liver Let Die: Dying Liver Cells Disclose Cancer Diagnosis
The methylation patterns of DNA in the blood offer insight into the liver disease stage
Loading Comments...